Kagan Cocozza Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Sell
2,385
-18
-0.7% -$18.4K 1.79% 14
2026
Q1
$2.21M Sell
2,403
-187
-7% -$190K 1.56% 14
2025
Q4
$2.78M Sell
2,590
-16
-0.6% -$15.3K 1.98% 13
2025
Q3
$1.99M Sell
2,606
-9
-0.3% -$6.7K 1.51% 15
2025
Q2
$2.04M Sell
2,615
-25
-0.9% -$19.4K 1.56% 15
2025
Q1
$2.18M Sell
2,640
-112
-4% -$93.2K 1.78% 14
2024
Q4
$2.12M Buy
+2,752
New +$2.28M 1.76% 14

Other funds holding LLY

Kagan Cocozza Asset Management's LLY Position: Q2 2026 in Review

Kagan Cocozza Asset Management reduced its Eli Lilly (LLY) stake by 0.75% in Q2 2026, selling an estimated $18.4K and leaving 2,385 shares worth $2.86M. The position accounts for 1.79% of the portfolio, ranked #14.

Kagan Cocozza Asset Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kagan Cocozza Asset Management held 2,385 shares of Eli Lilly worth $2.86M as of Q2 2026.
  • Kagan Cocozza Asset Management sold 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 1.79% of Kagan Cocozza Asset Management's portfolio in Q2 2026, its #14 holding.
  • Kagan Cocozza Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kagan Cocozza Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.